159 related articles for article (PubMed ID: 22077521)
1. Recent advances in hematology: an update from the 16th Congress of the EHA.
O'Neill T
Expert Rev Hematol; 2011 Dec; 4(6):587-9. PubMed ID: 22077521
[TBL] [Abstract][Full Text] [Related]
2. [International Congress of the American Society of Hematology, Philadelphia, 6-10 December 2002].
Veyssier-Belot C;
Rev Med Interne; 2003 Jul; 24(7):485-90. PubMed ID: 12829227
[No Abstract] [Full Text] [Related]
3. [Five breakthroughs for hematology].
Palmblad J
Lakartidningen; 2000 Feb; 97(5):472-3. PubMed ID: 10707500
[No Abstract] [Full Text] [Related]
4. Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era.
Van Etten RA
Leuk Res; 2004 May; 28 Suppl 1():S21-8. PubMed ID: 15036938
[TBL] [Abstract][Full Text] [Related]
5. Innovation in hematology. Perspectives: CML 2016.
Hehlmann R
Haematologica; 2016 Jun; 101(6):657-9. PubMed ID: 27252510
[No Abstract] [Full Text] [Related]
6. A summer of hematologic science. Highlights from the 45th Annual Meeting of the American Society of Clinical Oncology, the 14th Congress of the European Hematology Association, and the 2009 Pan Pacific Lymphoma Conference.
Cheson BD; Ashforth E
Clin Adv Hematol Oncol; 2009 Sep; 7(9 Suppl 15):1-22; quiz 23-4. PubMed ID: 20102012
[No Abstract] [Full Text] [Related]
7. Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.
Ali MA
Mol Diagn Ther; 2016 Aug; 20(4):315-33. PubMed ID: 27220498
[TBL] [Abstract][Full Text] [Related]
8. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies.
Einsele H; Briones J; Ciceri F; García Cadenas I; Falkenburg F; Bolaños N; Heemskerk HMM; Houot R; Hudecek M; Locatelli F; Morgan K; Morris EC; O'Dwyer M; Sierra JG; van den Brink M; van de Loosdrecht AA
Hemasphere; 2021 Oct; 5(10):e642. PubMed ID: 34522844
[No Abstract] [Full Text] [Related]
9. Molecular mechanisms of transformation by the BCR-ABL oncogene.
Sattler M; Griffin JD
Semin Hematol; 2003 Apr; 40(2 Suppl 2):4-10. PubMed ID: 12783368
[TBL] [Abstract][Full Text] [Related]
10. The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders.
Eichinger S; Morange PE; Cattaneo M; Fretigny M; Rauch A; van Hylckama Vlieg A; Trégouët DA; Ruf W; Levi M; Páramo JA; van der Poll T; Kyrle PA; Garagiola I; Peyvandi F
Hemasphere; 2021 Oct; 5(10):e643. PubMed ID: 34522845
[No Abstract] [Full Text] [Related]
11. Hematological and molecular response evaluation of CML patients on imatinib.
Gupta A; Prasad K
J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
Ren R
Nat Rev Cancer; 2005 Mar; 5(3):172-83. PubMed ID: 15719031
[TBL] [Abstract][Full Text] [Related]
13. [48th World Congress of the American Society of Hematology].
L'Allemain G;
Bull Cancer; 2007 May; 94(5):489-94. PubMed ID: 17535788
[No Abstract] [Full Text] [Related]
14. The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Engert A; Balduini C; Brand A; Coiffier B; Cordonnier C; Döhner H; de Wit TD; Eichinger S; Fibbe W; Green T; de Haas F; Iolascon A; Jaffredo T; Rodeghiero F; Salles G; Schuringa JJ;
Haematologica; 2016 Feb; 101(2):115-208. PubMed ID: 26819058
[TBL] [Abstract][Full Text] [Related]
15. The European Hematology Association: strengthening hematology in Europe and beyond.
Foà R
Expert Rev Hematol; 2011 Apr; 4(2):133-6. PubMed ID: 21495922
[TBL] [Abstract][Full Text] [Related]
16. Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation.
Melo JV; Deininger MW
Hematol Oncol Clin North Am; 2004 Jun; 18(3):545-68, vii-viii. PubMed ID: 15271392
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukaemia with BCR-ABL fusion genes located to both chromosomes 9, cyclic leukocytosis and nodal T-lymphoblastic transformation--durable complete remission following imatinib therapy.
Dufva IH; Karle H; Brondum-Nielsen K; Andersen MK; Madsen HO; Johnsen HE
Leukemia; 2005 Apr; 19(4):671-3. PubMed ID: 15703782
[No Abstract] [Full Text] [Related]
18. European Hematology Association - 20th Annual Congress (June 11-14, 2015 - Vienna, Austria).
Croasdell G
Drugs Today (Barc); 2015 Jul; 51(7):441-5. PubMed ID: 26261846
[TBL] [Abstract][Full Text] [Related]
19. The EHA Research Roadmap: Transfusion Medicine.
Stanworth SJ; Brand A; Kaveri SV; Vrielink H; Greinacher A; Domanović D; von Lindern M; Allard S; Bayry J; Bohonek M; Buser A; Claas FHJ; Knutson F; Lozano M; Olsson ML; Pirenne F; Rebulla P; So-Osman C; Tissot JD; Toye AM; Ushiro-Lumb I; van den Akker E; Zeerleder S
Hemasphere; 2022 Feb; 6(2):e670. PubMed ID: 35098039
[No Abstract] [Full Text] [Related]
20. [Achievements and developmental prospects in clinical hematology].
Faĭnshteĭn FE
Probl Gematol Pereliv Krovi; 1982 Nov; 27(11):3-10. PubMed ID: 7156079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
